References
- Daniels SR. Complications of obesity in children and adolescents. Int J Obes (Lond) 2009;33(Suppl 1):S60-5
- Lakshman R, Elks CE, Ong KK. Childhood obesity. Circulation 2012;126(14):1770-9
- Astrup A, Finer N. Redefining type 2 diabetes: ‘diabesity’ or ‘obesity dependent diabetes mellitus’? Obes Rev 2000;1(2):57-9
- Cornier MA, Marshall JA, Hill JO, et al. Prevention of overweight/obesity as a strategy to optimize cardiovascular health. Circulation 2011;124(7):840-50
- Kahn BB, Flier JS. Obesity and insulin resistance. J Clin Invest 2000;106(4):473-81
- Arcaro G, Cretti A, Balzano S, et al. Insulin causes endothelial dysfunction in humans: sites and mechanisms. Circulation 2002;105(5):576-82
- Kearney MT, Duncan ER, Kahn M, Wheatcroft SB. Insulin resistance and endothelial cell dysfunction: studies in mammalian models. Exp Physiol 2008;93(1):158-63
- Rask-Madsen C, Kahn CR. Tissue-specific insulin signaling, metabolic syndrome, and cardiovascular disease. Arterioscler Thromb Vasc Biol 2012;32(9):2052-9
- Tabit CE, Shenouda SM, Holbrook M, et al. Protein kinase C-beta contributes to impaired endothelial insulin signaling in humans with diabetes mellitus. Circulation 2013;127(1):86-95
- Gokce N. Clinical assessment of endothelial function: ready for prime time? Circ Cardiovasc Imaging 2011;4(4):348-50
- Bigornia SJ, Farb MG, Tiwari S, et al. Insulin status and vascular responses to weight loss in obesity. J Am Coll Cardiol 2013;62(24):2297-305
- Pierce GL, Beske SD, Lawson BR, et al. Weight loss alone improves conduit and resistance artery endothelial function in young and older overweight/obese adults. Hypertension 2008;52(1):72-9
- Sjostrom L, Peltonen M, Jacobson P, et al. Bariatric surgery and long-term cardiovascular events. JAMA 2012;307(1):56-65
- Norbert Stefan M, Hans-Ulrich H, Frank BH, Matthias BS. Metabolically healthy obesity: epidemiology, mechanisms, and clinical implications. Lancet Diabetes Endocrinol 2013;1(2):152-62
- Farb MG, Bigornia S, Mott M, et al. Reduced adipose tissue inflammation represents an intermediate cardiometabolic phenotype in obesity. J Am Coll Cardiol 2011;58(3):232-7
- Durward CM, Hartman TJ, Nickols-Richardson SM. All-cause mortality risk of metabolically healthy obese individuals in NHANES III. J Obes 2012;2012:460321
- Look ARG, Wing RR, Bolin P, et al. Cardiovascular effects of intensive lifestyle intervention in type 2 diabetes. N Engl J Med 2013;369(2):145-54
- Anderson TJ. Insulin as a biomarker to predict vascular protection from weight loss therapy. J Am Coll Cardiol 2013;62(24):2306-7